Merck Says Antiviral Pill for COVID-19 Is Effective, Plans to File for Emergency Authorization

The antiviral, molnupiravir, cut the risk of hospitalization or death in half for adults who were deemed at risk but not hospitalized, according to a planned interim analysis of the trial.